These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36883293)

  • 1. MT-ATP6 mitochondrial disease identified by newborn screening reveals a distinct biochemical phenotype.
    Tise CG; Verscaj CP; Mendelsohn BA; Woods J; Lee CU; Enns GM; Stander Z; Hall PL; Cowan TM; Cusmano-Ozog KP
    Am J Med Genet A; 2023 Jun; 191(6):1492-1501. PubMed ID: 36883293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective diagnosis of MT-ATP6-related mitochondrial disease by newborn screening.
    Peretz RH; Ah Mew N; Vernon HJ; Ganetzky RD
    Mol Genet Metab; 2021; 134(1-2):37-42. PubMed ID: 34176718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MT-ATP6 mitochondrial disease variants: Phenotypic and biochemical features analysis in 218 published cases and cohort of 14 new cases.
    Ganetzky RD; Stendel C; McCormick EM; Zolkipli-Cunningham Z; Goldstein AC; Klopstock T; Falk MJ
    Hum Mutat; 2019 May; 40(5):499-515. PubMed ID: 30763462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of orotic acid measurement in routine newborn screening for urea cycle disorders.
    Staretz-Chacham O; Daas S; Ulanovsky I; Blau A; Rostami N; Saraf-Levy T; Abu Salah N; Anikster Y; Banne E; Dar D; Dumin E; Fattal-Valevski A; Falik-Zaccai T; Hershkovitz E; Josefsberg S; Khammash H; Keidar R; Korman SH; Landau Y; Lerman-Sagie T; Mandel D; Mandel H; Marom R; Morag I; Nadir E; Yosha-Orpaz N; Pode-Shakked B; Pras E; Reznik-Wolf H; Saada A; Segel R; Shaag A; Shaul Lotan N; Spiegel R; Tal G; Vaisid T; Zeharia A; Almashanu S
    J Inherit Metab Dis; 2021 May; 44(3):606-617. PubMed ID: 33190319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel mutation m.8561C>G in MT-ATP6/8 causing a mitochondrial syndrome with ataxia, peripheral neuropathy, diabetes mellitus, and hypergonadotropic hypogonadism.
    Kytövuori L; Lipponen J; Rusanen H; Komulainen T; Martikainen MH; Majamaa K
    J Neurol; 2016 Nov; 263(11):2188-2195. PubMed ID: 27502083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newborn screening for proximal urea cycle disorders: Current evidence supporting recommendations for newborn screening.
    Merritt JL; Brody LL; Pino G; Rinaldo P
    Mol Genet Metab; 2018 Jun; 124(2):109-113. PubMed ID: 29703588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leigh Syndrome due to
    Akar HT; Sayar E; Sarıtaş Nakip Ö; Sönmez E; Özkan MB; Olgaç A
    Mol Syndromol; 2024 Aug; 15(4):333-338. PubMed ID: 39119452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenic variants in MT-ATP6: A United Kingdom-based mitochondrial disease cohort study.
    Ng YS; Martikainen MH; Gorman GS; Blain A; Bugiardini E; Bunting A; Schaefer AM; Alston CL; Blakely EL; Sharma S; Hughes I; Lim A; de Goede C; McEntagart M; Spinty S; Horrocks I; Roberts M; Woodward CE; Chinnery PF; Horvath R; Nesbitt V; Fratter C; Poulton J; Hanna MG; Pitceathly RDS; Taylor RW; Turnbull DM; McFarland R
    Ann Neurol; 2019 Aug; 86(2):310-315. PubMed ID: 31187502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. m.8993T>G-Associated Leigh Syndrome with Hypocitrullinemia on Newborn Screening.
    Mori M; Mytinger JR; Martin LC; Bartholomew D; Hickey S
    JIMD Rep; 2014; 17():47-51. PubMed ID: 25240982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical signatures mimicking multiple carboxylase deficiency in children with mutations in MT-ATP6.
    Larson AA; Balasubramaniam S; Christodoulou J; Burrage LC; Marom R; Graham BH; Diaz GA; Glamuzina E; Hauser N; Heese B; Horvath G; Mattman A; van Karnebeek C; Lane Rutledge S; Williamson A; Estrella L; Van Hove JKL; Weisfeld-Adams JD
    Mitochondrion; 2019 Jan; 44():58-64. PubMed ID: 29307858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding the clinical phenotypes of MT-ATP6 mutations.
    López-Gallardo E; Emperador S; Solano A; Llobet L; Martín-Navarro A; López-Pérez MJ; Briones P; Pineda M; Artuch R; Barraquer E; Jericó I; Ruiz-Pesini E; Montoya J
    Hum Mol Genet; 2014 Dec; 23(23):6191-200. PubMed ID: 24986921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Leigh syndrome caused by the mitochondrial m.8993T>G mutation with hypocitrullinemia: a report of four cases and literature review].
    Li YX; Wang DJ; Zhou MB; Sun HX; Hong SQ; Jiang L; Guo Y
    Zhongguo Dang Dai Er Ke Za Zhi; 2024 Sept 15; 26(9):940-945. PubMed ID: 39267509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathy, Ataxia, and Retinitis Pigmentosa Syndrome.
    Finsterer J
    J Clin Neuromuscul Dis; 2023 Mar; 24(3):140-146. PubMed ID: 36809201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole mitochondrial genome analysis of a family with NARP/MILS caused by m.8993T>C mutation in the MT-ATP6 gene.
    Kara B; Arıkan M; Maraş H; Abacı N; Cakıris A; Ustek D
    Mol Genet Metab; 2012 Nov; 107(3):389-93. PubMed ID: 22819295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotype-phenotype analysis of MT-ATP6-associated Leigh syndrome.
    Na JH; Lee YM
    Acta Neurol Scand; 2022 Apr; 145(4):414-422. PubMed ID: 34877647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel MT-ATP6 variant associated with complicated ataxia in two unrelated Italian patients: case report and functional studies.
    Sala D; Marchet S; Nanetti L; Legati A; Mariotti C; Lamantea E; Ghezzi D; Catania A; Lamperti C
    Orphanet J Rare Dis; 2024 May; 19(1):200. PubMed ID: 38755691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leigh-Like Syndrome Due to Homoplasmic m.8993T>G Variant with Hypocitrullinemia and Unusual Biochemical Features Suggestive of Multiple Carboxylase Deficiency (MCD).
    Balasubramaniam S; Lewis B; Mock DM; Said HM; Tarailo-Graovac M; Mattman A; van Karnebeek CD; Thorburn DR; Rodenburg RJ; Christodoulou J
    JIMD Rep; 2017; 33():99-107. PubMed ID: 27450367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Episodic weakness due to mitochondrial DNA MT-ATP6/8 mutations.
    Auré K; Dubourg O; Jardel C; Clarysse L; Sternberg D; Fournier E; Laforêt P; Streichenberger N; Petiot P; Gervais-Bernard H; Vial C; Bedat-Millet AL; Drouin-Garraud V; Bouillaud F; Vandier C; Fontaine B; Lombès A
    Neurology; 2013 Nov; 81(21):1810-8. PubMed ID: 24153443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Heterogeneity in
    Capiau S; Smet J; De Paepe B; Yildiz Y; Arslan M; Stevens O; Verschoore M; Stepman H; Seneca S; Vanlander A
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel genetic and neuropathological insights in neurogenic muscle weakness, ataxia, and retinitis pigmentosa (NARP).
    Claeys KG; Abicht A; Häusler M; Kleinle S; Wiesmann M; Schulz JB; Horvath R; Weis J
    Muscle Nerve; 2016 Aug; 54(2):328-33. PubMed ID: 27015314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.